Health Condition 1: null- Cardiometabolic Diseases such as Cardiovascular Diseases, Type II Diabetes, Stroke, Hypertension, Chronic Kidney Diseases Health Condition 2: I639- Cerebral infarction, unspecified Health Condition 3: N189- Chronic kidney disease, unspecified Health Condition 4: I10- Essential (primary) hypertension Health Condition 5: I519- Heart disease, unspecified Health Condition 6: E118- Type 2 diabetes mellitus with unspecified complications
Conditions
Interventions
Intervention1: Not applicable: Not applicable
Control Intervention1: Not applicable: Not applicable
Sponsors
National Heart Lung and Blood Institute NHLBI under the National Institutes of Health NIH USA
Eligibility
Inclusion criteria
Inclusion criteria: Adults aged 20 years and more living in the urban areas of Delhi and Chennai
Exclusion criteria
Exclusion criteria: Pregnant women and bed-ridden individuals
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Through piloting this cohort-modeled community-based surveillance plan and capturing broad-ranging data (including underlying lifestyle habits and risk factors, incident events and target organ damage, morbidity and mortality, as well as qualitative themes such as quality of life, health-seeking behaviors, health care utilization, cost of care, and quality of care delivery), we hope to underscore: 8 a. The need to overlay these pilot studies with sustained, efficient measurement systems for key cardiometabolic disease determinants and outcomes at sentinel sites with a view to examining trends over time, and b. The importance, feasibility, and benefits of maintaining and eventually expanding this initial surveillance infrastructure at other selected sites around the country, with gradual maturation to comprehensive data systems.Timepoint: | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactProf Dorairaj Prabhakaran
Executive Director Center for Chronic Disease Control (CCDC)
Outcome results
None listed